Oral Hormone Replacement Therapy Raises Blood Clot Risk
Key Points Oral hormone replacement therapy was associated with a higher risk of venous thromboembolism (VTE) among women aged 50–69
Read MoreKey Points Oral hormone replacement therapy was associated with a higher risk of venous thromboembolism (VTE) among women aged 50–69
Read MoreKey Points Early menopause affects more than 7% (1 in 14) of women aged 30–49 in low- and middle-income countries
Read MoreKey Summary A new study published in npj Women’s Health found that daily physical activity may be linked to estradiol
Read MoreKey Highlights A 3-million-cell atlas reveals how aging reshapes breast tissue Decline in immune surveillance may allow cancer cells to
Read MoreA major longitudinal study from Canada has brought new clarity to an area of ongoing debate in women’s health: the
Read MoreEndometriosis significantly increases the risk of both early menopause and surgical menopause, according to a groundbreaking international study led by
Read MoreResearchers examined the relationship between hormone therapy (HT) and the variation in the chronological and biological ages of postmenopausal women,
Read MoreA new research report from Brigham and Women’s Hospital and collaborators suggests that menopause does not always increase the risk
Read MoreSex hormones cause changes in central learning and memory hubs. Rachel Zsido and Julia Sacher of the Max Planck Institute
Read MoreOn May 12, Astellas Pharma Inc announced that the FDA had approved VEOZAHTM (fezolinetant) 45 mg once daily for the
Read More